These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 977134)

  • 1. Clinical study on the antifungal activity of griseofulvin in the presence of surfactants.
    Said S; Mahrous H; Kassem A
    Infection; 1976; 4(2):49-50. PubMed ID: 977134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral treatment of tinea corporis and tinea cruris with terbinafine and griseofulvin: a randomized double blind comparative study.
    Voravutinon V
    J Med Assoc Thai; 1993 Jul; 76(7):388-93. PubMed ID: 8089640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
    Panagiotidou D; Kousidou T; Chaidemenos G; Karakatsanis G; Kalogeropoulou A; Teknetzis A; Chatzopoulou E; Michailidis D
    J Int Med Res; 1992 Sep; 20(5):392-400. PubMed ID: 1333423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris.
    Bourlond A; Lachapelle JM; Aussems J; Boyden B; Campaert H; Conincx S; Decroix J; Geeraerts C; Ghekiere L; Morias J
    Int J Dermatol; 1989; 28(6):410-2. PubMed ID: 2548967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis.
    Cole GW; Stricklin G
    Arch Dermatol; 1989 Nov; 125(11):1537-9. PubMed ID: 2684023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
    Lachapelle JM; De Doncker P; Tennstedt D; Cauwenbergh G; Janssen PA
    Dermatology; 1992; 184(1):45-50. PubMed ID: 1313717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind study of ketoconazole and griseofulvin in dermatophytoses.
    Martínez-Roig A; Torres-Rodríguez JM; Bartlett-Coma A
    Pediatr Infect Dis J; 1988 Jan; 7(1):37-40. PubMed ID: 3277154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topical griseofulvin in treatment of tinea corporis.
    Kassem MA; Esmat S; Bendas ER; El-Komy MH
    Mycoses; 2006 May; 49(3):232-5. PubMed ID: 16681816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris.
    Faergemann J; Mörk NJ; Haglund A; Odegård T
    Br J Dermatol; 1997 Apr; 136(4):575-7. PubMed ID: 9155961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of ringworm in calves using griseofulvin.
    Andrews AH; Edwardson J
    Vet Rec; 1981 Jun; 108(23):498-500. PubMed ID: 7303434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapse and resistance of ringworm infection following griseofulvin treatment.
    Banerjee AK
    Bull Calcutta Sch Trop Med; 1969 Apr; 17(2):52-3. PubMed ID: 5401890
    [No Abstract]   [Full Text] [Related]  

  • 13. Personal hygiene as an alternative to griseofulvin in the treatment of tinea cruris.
    Akinwale SO
    Afr J Med Med Sci; 2000 Mar; 29(1):41-3. PubMed ID: 11379466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of patients suffering from trichomycosis and onychomycosis with griseofulvin, keratolytic and fungicidal plasters].
    Tadzhibaev TT; Areshev VI; Efremova VA
    Vestn Dermatol Venerol; 1968 Jul; 42(7):78-81. PubMed ID: 4243178
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of terbinafine versus griseofulvin in 'dry-type' dermatophyte infections.
    Hay RJ; Logan RA; Moore MK; Midgely G; Clayton YM
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):243-6. PubMed ID: 2007669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus.
    Wishart JM
    N Z Med J; 1994 Apr; 107(975):126-8. PubMed ID: 8145958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
    Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
    Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
    Goh CL; Tay YK; Ali KB; Koh MT; Seow CS
    Int J Dermatol; 1994 Oct; 33(10):733-7. PubMed ID: 8002147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
    Savin RC
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical griseofulvin in dermatophytoses.
    Montes LF; Nimni M
    Skinmed; 2011; 9(2):134-5. PubMed ID: 21548526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.